.Pharmacolibrary.Drugs.R_RespiratorySystem.R01A_DecongestantsAndOtherNasalPreparationsForTopical.R01AD57_TixocortolCombinations.TixocortolCombinations .Pharmacolibrary.Drugs.R_RespiratorySystem.R01A_DecongestantsAndOtherNasalPreparationsForTopical.R01AD57_TixocortolCombinations.TixocortolCombinations| name: | TixocortolCombinations | |
| ATC code: | R01AD57 | route: | nasal |
| compartments: | 1 | |
| dosage: | 1 | mg |
| volume of distribution: | 10 | L |
| clearance: | 15 | L/h |
| other parameters in model implementation | ||
Tixocortol is a corticosteroid with minimal systemic glucocorticoid effect, typically used topically for its anti-inflammatory and anti-allergic properties. In combination products, it is used for local treatment of nasal inflammatory conditions such as rhinitis. Tixocortol is not widely used or approved in most countries today; nasal formulations are largely historical.
There are no published studies directly reporting pharmacokinetic parameters for tixocortol in combination products administered via the nasal route in humans.